ArticleMaterials today. Bio2026
GenX exposure induces neurodevelopmental impairment and synaptic toxicity in hESC-derived cerebral organoids.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
GenX, also known as hexafluoropropylene oxide dimer acid (HFPO-DA), was introduced in 2009 as a purportedly safer alternative to perfluorooctanoic acid (PFOA). However, nearly two decades of use have raised increasing safety concerns owing to its reported association with multiple forms of organ damage. However, only a few studies have systematically evaluated the molecular mechanisms underlying the neurotoxicity of GenX exposure. In this study, we aimed to investigate the neurodevelopmental impairments and synaptic toxicity induced by GenX during cortical development using human embryonic stem cell-derived cerebral organoids. We found that early exposure to GenX resulted in reduced organoid size and concentration-dependent deficits in basal neural progenitor cell proliferation. Moreover, GenX exposure prior to differentiation impaired synapse formation and decreased the number of excitatory synapses. We also found that early GenX exposure disrupted neural activity and altered neural network organization. RNA sequencing and Gene Ontology analyses revealed that these effects were associated with dysregulation of neuropeptide signaling pathways, synapse assembly, and postsynaptic organization. Collectively, these impairments in neurogenesis and neural activity indicate that GenX exerts neurotoxic effects and may pose a potential risk factor for neurodevelopmental disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.